To address this knowledge gap, we assessed the CD8+ T cell immune phenotype as well as PD-1 and LAG-3 expression in primary tumors (PBTs) with intrapatient matched distant metastases (METs) in a retrospective cohort of 95 breast cancer patients by using immunohistochemistry on whole sections. This evidence concerns the gene LAG3 and breast carcinoma.